No abstract available
MeSH terms
-
Anemia / blood
-
Anemia / mortality
-
Anemia / therapy*
-
Blood Substitutes / adverse effects
-
Blood Substitutes / therapeutic use*
-
Blood Transfusion
-
Compassionate Use Trials*
-
Contraindications
-
Drug Approval
-
Evidence-Based Medicine
-
Hemoglobins / adverse effects
-
Hemoglobins / therapeutic use*
-
Humans
-
Risk Assessment
-
Risk Factors
-
Severity of Illness Index
-
Time Factors
-
Treatment Outcome
-
Treatment Refusal
-
United States
-
United States Food and Drug Administration
Substances
-
Blood Substitutes
-
Hemoglobins
-
HBOC 201